A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2002
12/05/2002	US20020182208 Glycosylated antibody
12/05/2002	US20020182185 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/05/2002	US20020182181 Generated from a bacteriophage; gene expression inhibition
12/05/2002	US20020182180 Method for inducing immunity to viruses
12/05/2002	DE10125179A1 Verwendung von LPS zur Behandlung intestinaler Entzündungsprozesse Use of LPS to treat intestinal inflammation
12/05/2002	CA2449127A1 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2449026A1 Use of polyclonal immunoglobulins
12/05/2002	CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448567A1 Modulators of nucleic acid ligands
12/05/2002	CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448345A1 Stable liquid formulations of antibodies
12/05/2002	CA2448305A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448146A1 Secreted proteins
12/05/2002	CA2448116A1 Molecules for disease detection and treatment
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448096A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447662A1 Transporters and ion channels
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446723A1 Antibodies that immunospecifically bind to trail receptors
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/04/2002	EP1262491A2 Non-anaphylactogenic IgE vaccines
12/04/2002	EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002	EP1262189A1 Leptin-resistance ameliorating agents
12/04/2002	EP1262183A1 Use of norastemizole for the treatment of allergic rhinitis
12/04/2002	EP1261744A2 Estrogen receptor beta variants and methods of detection thereof
12/04/2002	EP1261736A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides
12/04/2002	EP1261714A2 Muteins of interleukin-13 (il-13)
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002	EP1261694A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
12/04/2002	EP1261643A1 Composition for inhibiting macrophage activity
12/04/2002	EP1261638A2 Human fgf-23 gene and gene expression products
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261627A2 Antibodies against plasma cells
12/04/2002	EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002	EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002	EP1261585A1 Substituted indole mannich bases
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261377A2 Immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261376A1 Antibodies against ctla4(cd152), conjugates comprising same, and uses thereof
12/04/2002	EP1261370A1 Therapeutic method for reducing angiogenesis
12/04/2002	EP1261366A1 Adjuvant treatment by in vivo activation of dendritic cells
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261360A1 Casein derived peptides and uses thereof in therapy
12/04/2002	EP1261359A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof
12/04/2002	EP1261355A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1261327A2 Adenosine receptor modulators
12/04/2002	EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002	EP1109529B1 Use of a lipid extract of the skeletonema algae
12/04/2002	EP1005342B1 Pharmaceutical compositions of tizoxanide and nitazoxanide
12/04/2002	EP0824358B1 Acellular pertussis vaccines and methods of preparation thereof
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	EP0714441B1 Recombinant cladosporium herbarum allergens
12/04/2002	EP0650356B1 Rapamycin derivatives
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1383450A Antibody molecules having specificity for huamn tumor necrosis factory alpha, and use thereof
12/04/2002	CN1383384A Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof
12/04/2002	CN1382476A Application of yellowstem milkwort in preparing medicines
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489326 Sodium nucleinate, 2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, used as an immunomodulator, which also has antiinflammatory and antioxidant properties
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489299 Lysine at position 91 is altered to another amino acid.
12/03/2002	US6489130 Death associated kinase containing ankyrin repeats (DAKAR)
12/03/2002	US6489118 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies
12/03/2002	US6488936 Glycoprotein d of herpes simplex type i and type ii
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway

1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 1172